skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 72,381  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Respiratory System remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial
Material Type:
Article 		Add to My Research

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.1732-1742 [Peer Reviewed Journal]

2019 ;Copyright © 2019 by the International Association for the Study of Lung Cancer ;Published by Elsevier Inc. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2019.05.044 ;PMID: 31260833

Full text available

Citations Cited by
2
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Material Type:
Article 		Add to My Research

Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival

Thoracic cancer, 2020-07, Vol.11 (7), p.1911-1917 [Peer Reviewed Journal]

2020 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd ;2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.13481 ;PMID: 32401433

Full text available

Citations Cited by
3
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
Material Type:
Article 		Add to My Research

Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling

American journal of respiratory and critical care medicine, 2016-03, Vol.193 (5), p.542-551 [Peer Reviewed Journal]

Copyright American Thoracic Society Mar 1, 2016 ;ISSN: 1073-449X ;EISSN: 1535-4970 ;DOI: 10.1164/rccm.201505-1040OC ;PMID: 26485620

Full text available

Citations Cited by
4
Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
Material Type:
Article 		Add to My Research

Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease

Thoracic cancer, 2018-07, Vol.9 (7), p.847-855 [Peer Reviewed Journal]

2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd ;2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. ;COPYRIGHT 2018 John Wiley & Sons, Inc. ;2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.12759 ;PMID: 29782069

Full text available

Citations Cited by
5
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Material Type:
Article 		Add to My Research

Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.77-84 [Peer Reviewed Journal]

2016 International Association for the Study of Lung Cancer ;Copyright © 2017 by the International Association for the Study of Lung Cancer ;Copyright © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;2016 International Association for the Study of Lung Cancer. Elsevier Inc. All rights reserved. 2016 International Association for the Study of Lung Cancer ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2016.08.123 ;PMID: 27544059

Full text available

Citations Cited by
6
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
Material Type:
Article 		Add to My Research

Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.494-502 [Peer Reviewed Journal]

2018 International Association for the Study of Lung Cancer ;Copyright © 2019 by the International Association for the Study of Lung Cancer ;Copyright © 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2018.11.016 ;PMID: 30503891

Full text available

Citations Cited by
7
Switching administration of anti‐PD‐1 and anti‐PD‐L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non‐small cell lung cancer: Case series and literature review
Switching administration of anti‐PD‐1 and anti‐PD‐L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non‐small cell lung cancer: Case series and literature review
Material Type:
Article 		Add to My Research

Switching administration of anti‐PD‐1 and anti‐PD‐L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non‐small cell lung cancer: Case series and literature review

Thoracic cancer, 2020-07, Vol.11 (7), p.1927-1933 [Peer Reviewed Journal]

2020 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd ;2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.13483 ;PMID: 32421224

Full text available

Citations Cited by
8
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD
Material Type:
Article 		Add to My Research

Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD

International journal of chronic obstructive pulmonary disease, 2019-08, Vol.14, p.1867-1877 [Peer Reviewed Journal]

2019 Suzuki et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Suzuki et al. 2019 Suzuki et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S214610 ;PMID: 31686799

Full text available

Citations Cited by
9
Advances in Optical Coherence Tomography and Confocal Laser Endomicroscopy in Pulmonary Diseases
Advances in Optical Coherence Tomography and Confocal Laser Endomicroscopy in Pulmonary Diseases
Material Type:
Article 		Add to My Research

Advances in Optical Coherence Tomography and Confocal Laser Endomicroscopy in Pulmonary Diseases

Respiration, 2020-03, Vol.99 (3), p.190-205 [Peer Reviewed Journal]

The Author(s). Published by S. Karger AG, Basel ;ISSN: 0025-7931 ;EISSN: 1423-0356 ;DOI: 10.1159/000503261 ;PMID: 31593955

Digital Resources/Online E-Resources

Citations Cited by
10
Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
Material Type:
Article 		Add to My Research

Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)

Thoracic cancer, 2020-03, Vol.11 (3), p.511-518 [Peer Reviewed Journal]

2020 The Author. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd ;2020 The Author. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.13328 ;PMID: 31989769

Full text available

Citations Cited by
11
Cystic Lung Diseases: Algorithmic Approach
Cystic Lung Diseases: Algorithmic Approach
Material Type:
Article 		Add to My Research

Cystic Lung Diseases: Algorithmic Approach

Chest, 2016-10, Vol.150 (4), p.945-965 [Peer Reviewed Journal]

Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. ;Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. 2016 American College of Chest Physicians ;ISSN: 0012-3692 ;EISSN: 1931-3543 ;DOI: 10.1016/j.chest.2016.04.026 ;PMID: 27180915

Full text available

Citations Cited by
12
Association between serum biomarkers CEA and LDH and response in advanced non‐small cell lung cancer patients treated with platinum‐based chemotherapy
Association between serum biomarkers CEA and LDH and response in advanced non‐small cell lung cancer patients treated with platinum‐based chemotherapy
Material Type:
Article 		Add to My Research

Association between serum biomarkers CEA and LDH and response in advanced non‐small cell lung cancer patients treated with platinum‐based chemotherapy

Thoracic cancer, 2020-07, Vol.11 (7), p.1790-1800 [Peer Reviewed Journal]

2020 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd ;2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.13449 ;PMID: 32383328

Full text available

Citations Cited by
13
Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma
Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma
Material Type:
Article 		Add to My Research

Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma

Respiratory research, 2024-01, Vol.25 (1), p.59-59, Article 59 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-024-02691-8 ;PMID: 38273401

Full text available

Citations Cited by
14
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
Material Type:
Article 		Add to My Research

Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients

International journal of chronic obstructive pulmonary disease, 2019-05, Vol.14, p.929-938 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Lim et al. 2019 Lim et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S190244 ;PMID: 31118602

Full text available

Citations Cited by
15
Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial
Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial
Material Type:
Article 		Add to My Research

Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial

Respiratory research, 2020-05, Vol.21 (1), p.129-129, Article 129 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2020 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-020-01392-2 ;PMID: 32450847

Full text available

Citations Cited by
16
Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer
Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer
Material Type:
Article 		Add to My Research

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer

Thoracic cancer, 2020-04, Vol.11 (4), p.1052-1060 [Peer Reviewed Journal]

2020 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd ;2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.13364 ;PMID: 32096610

Full text available

Citations Cited by
17
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype
Material Type:
Article 		Add to My Research

Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype

Journal of thoracic oncology, 2019-04, Vol.14 (4), p.617-627 [Peer Reviewed Journal]

2019 International Association for the Study of Lung Cancer ;Copyright © 2019 by the International Association for the Study of Lung Cancer ;Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2018.12.030 ;PMID: 30659988

Full text available

Citations Cited by
18
The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs
The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs
Material Type:
Article 		Add to My Research

The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs

Journal of thoracic oncology, 2016-06, Vol.11 (6), p.862-872 [Peer Reviewed Journal]

2016 International Association for the Study of Lung Cancer ;Copyright © 2016 by the International Association for the Study of Lung Cancer ;Copyright © 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;ISSN: 1556-0864 ;ISSN: 1556-1380 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2016.01.020 ;PMID: 26872818

Full text available

Citations Cited by
19
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer
Material Type:
Article 		Add to My Research

The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer

Journal of thoracic oncology, 2014-11, Vol.9 (11), p.1618-1624 [Peer Reviewed Journal]

2014 International Association for the Study of Lung Cancer ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1097/JTO.0000000000000334 ;PMID: 25436796

Full text available

Citations Cited by
20
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
Material Type:
Article 		Add to My Research

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer

European journal of cardio-thoracic surgery, 2014-05, Vol.45 (5), p.787-798 [Peer Reviewed Journal]

The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. 2014 ;ISSN: 1010-7940 ;EISSN: 1873-734X ;DOI: 10.1093/ejcts/ezu028 ;PMID: 24578407

Full text available

Citations Cited by

Results 1 - 20 of 72,381  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (67,373)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1961  (208)
  2. 1961 To 1975  (592)
  3. 1976 To 1990  (3,861)
  4. 1991 To 2006  (18,783)
  5. After 2006  (49,029)
  6. More options open sub menu

Language 

  1. English  (71,321)
  2. Japanese  (10,244)
  3. Portuguese  (553)
  4. French  (539)
  5. Spanish  (387)
  6. Turkish  (187)
  7. Korean  (164)
  8. German  (44)
  9. Norwegian  (28)
  10. Russian  (7)
  11. Chinese  (7)
  12. Italian  (6)
  13. Polish  (3)
  14. Romanian  (1)
  15. Czech  (1)
  16. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait